{"disease":{"id":"secondary-hyperparathyroidism","name":"Secondary hyperparathyroidism","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"etelcalcetide","indication_name":"Secondary Hyperparathyroidism in CKD on Hemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Parsabiv","generic_name":"ETELCALCETIDE","company_name":"Kai Pharms Inc","drug_phase":"marketed","molecular_target":"CaSR","drug_class":"Calcium-sensing Receptor Agonist","quality_score":70,"revenue":null,"mechanism":"Etelcalcetide enhances calcium-sensing receptor activation, reducing PTH secretion."},{"drug_id":"calcitriol-capsules","indication_name":"Secondary Hyperparathyroidism in Predialysis Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calcitriol capsules","company_name":"Indonesia University","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin D3 Analog [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"upacicalcet","indication_name":"Secondary hyperparathyroidism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Upasita","generic_name":"UPACICALCET","company_name":"SANWA KAGAKU KENKYUSHO Co., Ltd.","drug_phase":"marketed","molecular_target":"Extracellular calcium-sensing receptor","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"evocalcet","indication_name":"Secondary hyperparathyroidism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orkedia","generic_name":"EVOCALCET","company_name":"Kyowa Hakko Kirin Co., Ltd.","drug_phase":"marketed","molecular_target":"Extracellular calcium-sensing receptor","drug_class":"","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"etelcalcetide","indication_name":"Secondary hyperparathyroidism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Parsabiv","generic_name":"ETELCALCETIDE","company_name":"Kai Pharms Inc","drug_phase":"marketed","molecular_target":"CaSR","drug_class":"Calcium-sensing Receptor Agonist","quality_score":70,"revenue":null,"mechanism":"Etelcalcetide enhances calcium-sensing receptor activation, reducing PTH secretion."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00345839","title":"E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3883,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03194087","title":"the Study on Prognostic for Hemodialysis Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":827,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT01896232","title":"Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":683,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03299244","title":"Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06434961","title":"The Trial of SHR6508 in Secondary Hyperparathyroidism","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":498,"lead_sponsor_name":"Shanghai Hengrui Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03137316","title":"Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy","phase":"","overall_status":"COMPLETED","enrollment_count":437,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT07122401","title":"Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":424,"lead_sponsor_name":"Shaanxi Micot Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05836220","title":"Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":412,"lead_sponsor_name":"Pathalys Pharma","has_results":false},{"nct_id":"NCT03822507","title":"Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":404,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT05549154","title":"A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":372,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05832931","title":"Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"Pathalys Pharma","has_results":false},{"nct_id":"NCT00803712","title":"20070360 Incident Dialysis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06976177","title":"Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"Shaanxi Micot Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04922892","title":"Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT03626948","title":"SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","has_results":false},{"nct_id":"NCT03801980","title":"Phase 3 Study of SK-1403","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","has_results":false},{"nct_id":"NCT02549404","title":"Phase 3 Study of KHK7580","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT03464149","title":"The Longitudinal PTH-Study","phase":"","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT06690242","title":"MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Shaanxi Micot Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT06747247","title":"A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Shaanxi Micot Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04994080","title":"A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Chengdu Suncadia Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06378931","title":"Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Chunling Jiang","has_results":false},{"nct_id":"NCT05663411","title":"A Study of SHR6508 in Secondary Hyperparathyroidism","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Shanghai Hengrui Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03588884","title":"Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"OPKO Health, Inc.","has_results":true},{"nct_id":"NCT03660800","title":"Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"OPKO Health, Inc.","has_results":false},{"nct_id":"NCT01447368","title":"Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT01506947","title":"A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"AbbVie (prior sponsor, Abbott)","has_results":true},{"nct_id":"NCT03937349","title":"Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Saint Petersburg State University, Russia","has_results":false},{"nct_id":"NCT02133404","title":"A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03182699","title":"Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Rainer Oberbauer","has_results":false},{"nct_id":"NCT07151664","title":"Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT03226171","title":"Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","has_results":false},{"nct_id":"NCT03633708","title":"A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT02138838","title":"Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":55,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05221008","title":"A Trial of SHR6508 in Secondary Hyperparathyroidism","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Shanghai Hengrui Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03626246","title":"Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06398002","title":"The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Iain Bressendorff","has_results":false},{"nct_id":"NCT04267965","title":"Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05347082","title":"Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospital Regional 1o de Octubre","has_results":false},{"nct_id":"NCT03602261","title":"Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"OPKO Health, Inc.","has_results":true},{"nct_id":"NCT01277510","title":"Pediatric Chronic Kidney Disease Safety and Efficacy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05880914","title":"Precision Medicine Approaches to Renal Osteodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Thomas Nickolas","has_results":false},{"nct_id":"NCT02549417","title":"Phase 3 Study of KHK7580","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT01414114","title":"Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"KAI Pharmaceuticals","has_results":true},{"nct_id":"NCT06187480","title":"Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Mersin University","has_results":false},{"nct_id":"NCT03283098","title":"A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04484116","title":"IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hospital General Ajusco Medio","has_results":false},{"nct_id":"NCT02341417","title":"Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03969329","title":"A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT02859896","title":"Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Sanofi","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}